Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 8, 2002, Pages 677-680

  Crews, Kristine R ^a   Wimmer, Peggy S ^a   Hudson, Joanna Q ^a   Howard, Scott C ^a   Ribeiro, Raul C ^a   Razzouk, Bassem I ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

2 chlorodeoxyadenosine; Acute monoblastic leukemia; Cladribine; Leukemia; Pediatric; Pharmacokinetics; Renal failure

Indexed keywords

ANTIBIOTIC AGENT; CLADRIBINE; CYTARABINE; RASBURICASE; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ACUTE MONOCYTIC LEUKEMIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN DISEASE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INFUSION; HEMODIALYSIS; HEMOFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION; KIDNEY CLEARANCE; KIDNEY FUNCTION; LEUKAPHERESIS; LEUKOSTASIS; MALE; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHOOL CHILD; SENSORIMOTOR NEUROPATHY;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLOSIS; CHILD; CLADRIBINE; COMBINED MODALITY THERAPY; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FATAL OUTCOME; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; LEUKAPHERESIS; LEUKEMIA, MONOCYTIC, ACUTE; MALE; METABOLIC CLEARANCE RATE; RECOMBINANT PROTEINS; REMISSION INDUCTION; RENAL DIALYSIS; URATE OXIDASE;

EID: 0036843559     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200211000-00016     Document Type: Conference Paper

References (19)

1. Carson DA, Wasson DB, Taetle R, et al. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 1983;62:737-43.
2. Seto S, Carrera CJ, Kubota M, et al. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 1985;75:377-83.
3. Griffig J, Koob R, Blakley RL. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. Cancer Res 1989;49:6923-8.
4. Santana VM, Mirro J Jr, Kearns C, et al. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. J Clin Oncol 1992;10:364-70.
5. Santana VM, Hurwitz CA, Blakley RL. et al. Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia. Blood 1994;84:1237-42.
6. Krance RA, Hurwitz CA, Head DR, et al. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol 2001;19:2804-11.
7. Kornblau SM, Gandhi V, Andreeff HM, et al. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. Leukemia 1996;10:1563-9.
8. Gandhi V, Estey E, Keating MJ, et al. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: Pharmacokinetic, pharmacodynamic, and molecular interactions. Blood 1996;87:256-64.
9. Radomski KM, Gandhi V, Srivastava DK, et al. Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML). Blood 2000;96:327a.
10. Kearns CM, Blakley RL, Santana VM, et al. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia. Cancer Res 1994;54:1235-9.
11. Tobelem G, Jacquillat C, Chastang C, et al. Acute monoblastic leukemia: A clinical and biologic study of 74 cases. Blood 1980;55:71-6.
12. Poschl JM, Klaus G, Querfeld U, et al. Chemotherapy with cytosine arabinoside in a child with Burkitt's lymphoma on maintenance hemodialysis and hemofiltration. Ann Hematol 1993;67:37-9.
13. Albertioni F, Hemgren L, Juliusson G, et al. Protein binding of 2-chloro 2′-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemia. Eur J Clin Pharmacol 1994;46:563-4.
14. Santana VM, Mirro J Jr, Harwood FC, et al. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia. J Clin Oncol 1991;9:416-22.
15. Vahdat L, Wong ET, Wile MJ, et al. Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia. Blood 1994;84:3429-34.
16. Creutzig U, Ritter J, Budde M, et al. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer 1987;60:3071-9.
17. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985;3:1590-5.
18. Lazarus HM, Herzig RH, Herzig GP, et al. Central nervous system toxicity of high-dose systemic cytosine arabinoside. Cancer 1981;48:2577-82.
19. Lopez JA, Agarwal RP. Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside. Cancer Treat Rep 1984;68:1309-10.